VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 669 filers reported holding VANECK VECTORS ETF TR in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,471,977 | -10.6% | 54,700 | 0.0% | 0.62% | -13.8% |
| Q2 2023 | $1,647,017 | -6.9% | 54,700 | 0.0% | 0.72% | -22.5% |
| Q1 2023 | $1,769,545 | +77.9% | 54,700 | +57.6% | 0.93% | +94.4% |
| Q4 2022 | $994,502 | +18.8% | 34,700 | 0.0% | 0.48% | +1.3% |
| Q3 2022 | $837,000 | -11.9% | 34,700 | 0.0% | 0.47% | -5.2% |
| Q2 2022 | $950,000 | -28.6% | 34,700 | 0.0% | 0.50% | -22.1% |
| Q1 2022 | $1,331,000 | +2.1% | 34,700 | -14.7% | 0.64% | +20.1% |
| Q4 2021 | $1,304,000 | -58.1% | 40,700 | -61.5% | 0.53% | -54.1% |
| Q3 2021 | $3,115,000 | -13.3% | 105,700 | 0.0% | 1.16% | +27.3% |
| Q2 2021 | $3,592,000 | +4.6% | 105,700 | 0.0% | 0.91% | -1.3% |
| Q1 2021 | $3,435,000 | +5.1% | 105,700 | +16.5% | 0.92% | +4.8% |
| Q4 2020 | $3,267,000 | -8.0% | 90,700 | 0.0% | 0.88% | +47.4% |
| Q3 2020 | $3,552,000 | +6.8% | 90,700 | 0.0% | 0.60% | +50.0% |
| Q2 2020 | $3,327,000 | +59.2% | 90,700 | 0.0% | 0.40% | +73.8% |
| Q1 2020 | $2,090,000 | -21.3% | 90,700 | 0.0% | 0.23% | +40.5% |
| Q4 2019 | $2,656,000 | +9.6% | 90,700 | 0.0% | 0.16% | -15.1% |
| Q3 2019 | $2,423,000 | +56.2% | 90,700 | +49.4% | 0.19% | +50.0% |
| Q2 2019 | $1,551,000 | +14.0% | 60,700 | 0.0% | 0.13% | +21.9% |
| Q1 2019 | $1,361,000 | +32.5% | 60,700 | +24.6% | 0.10% | +23.5% |
| Q4 2018 | $1,027,000 | +34.6% | 48,700 | +18.2% | 0.08% | +51.8% |
| Q3 2018 | $763,000 | -17.0% | 41,200 | 0.0% | 0.06% | -9.7% |
| Q2 2018 | $919,000 | +1.4% | 41,200 | 0.0% | 0.06% | 0.0% |
| Q1 2018 | $906,000 | -5.3% | 41,200 | 0.0% | 0.06% | +3.3% |
| Q4 2017 | $957,000 | +1.2% | 41,200 | 0.0% | 0.06% | -20.0% |
| Q3 2017 | $946,000 | +21.8% | 41,200 | +17.0% | 0.08% | +44.2% |
| Q2 2017 | $777,000 | -3.2% | 35,200 | 0.0% | 0.05% | +8.3% |
| Q1 2017 | $803,000 | +9.1% | 35,200 | 0.0% | 0.05% | -5.9% |
| Q4 2016 | $736,000 | -20.9% | 35,200 | 0.0% | 0.05% | -38.6% |
| Q3 2016 | $930,000 | +40.5% | 35,200 | +47.3% | 0.08% | +48.2% |
| Q2 2016 | $662,000 | – | 23,900 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |